Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
Active, not recruiting · NCT05782465 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Not stated | 2026-08-07 | NCT05782465 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Taiwan University Hospital | Taipei | Taiwan | 203 |
| National University Hospital | Singapore | Singapore | 55 |
| Nihon University School of Medicine | Tokyo | Japan | 2 |
| Singapore General Hospital | Singapore | Singapore | 48 |
| Stanford University | Stanford | United States | 213 |
| Tan Tock Seng Hospital, Singapore | Singapore | Singapore | 2 |
| The Chinese University of Hong Kong | Hong Kong | Hong Kong | 57 |
| Yonsei University, Republic of Korea | Seoul | South Korea | 1 |